Wells Fargo Raises Imax PT to $34, Maintains Overweight Rating

Friday, Jul 25, 2025 10:39 am ET1min read
BOX--
IMAX--
WFC--

Wells Fargo Raises Imax PT to $34, Maintains Overweight Rating

Wells Fargo has raised its price target for IMAX Corporation (IMAX) to $34, while maintaining an overweight rating. The update comes following recent analyst forecasts and the company's mixed second-quarter results. Wells Fargo analyst Omar Mejias increased the target price from $30, reflecting the positive outlook on IMAX's growth prospects.

IMAX reported earnings of 26 cents per share for the second quarter, surpassing the consensus estimate of 21 cents. However, sales of $91.68 million missed the analyst consensus estimate of $92.51 million. The company attributed its strong financial performance to robust network growth and record box office in North America. CEO Rich Gelfond highlighted the company's momentum, citing 57 new IMAX locations opened worldwide and strong system sales.

In response to the earnings report, several analysts have adjusted their price targets. Rosenblatt analyst Steve Frankel raised the price target from $35 to $37, while Benchmark analyst Mike Hickey increased the target from $30 to $32. These changes reflect the analysts' optimism about IMAX's future performance.

Wells Fargo's latest update underscores the positive sentiment surrounding IMAX. The company's strong network expansion and box office performance have bolstered investor confidence. As IMAX continues to grow its global footprint, analysts expect the stock to benefit from increased demand for premium cinema experiences.

References:
[1] https://www.quiverquant.com/news/New+Analyst+Forecast%3A+%24IMAX+Given+%2432.0+Price+Target
[2] https://www.nasdaq.com/articles/new-analyst-forecast-imax-given-320-price-target
[3] https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46630180/imax-analysts-increase-their-forecasts-after-q2-results

Wells Fargo Raises Imax PT to $34, Maintains Overweight Rating

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet